- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Prognostic significance of ER-to-PR difference in ER+/HER2- early breast cancer ; volume:14 ; number:1 ; day:18 ; month:10 ; year:2024 ; pages:1-10 ; date:12.2024
Scientific reports ; 14, Heft 1 (18.10.2024), 1-10, 12.2024
- Creator
-
Wu, Xiaoyan
Zhang, Wenchuan
Lu, Xunxi
Zhong, Xiaorong
Bu, Hong
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-74608-w
- URN
-
urn:nbn:de:101:1-2501072111120.322179951285
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wu, Xiaoyan
- Zhang, Wenchuan
- Lu, Xunxi
- Zhong, Xiaorong
- Bu, Hong
- SpringerLink (Online service)
Other Objects (12)
Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2− breast cancers by the 2015 St. Gallen consensus classification
Prognostic significance of low HER2 expression in gastric cancer: a retrospective, single-center analysis
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
Targeted therapies for ER+/HER2- metastatic breast cancer
Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma
Prognostic significance of necrosis in ampullary carcinomas
The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases
Prognostic significance of PCNA grade in malignant melanoma
Prognostic significance of midwall fibrosis in dilated cardiomyopathy
Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2− breast cancers by the 2015 St. Gallen consensus classification
Prognostic significance of low HER2 expression in gastric cancer: a retrospective, single-center analysis
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
Targeted therapies for ER+/HER2- metastatic breast cancer
Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma
Prognostic significance of necrosis in ampullary carcinomas
The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases
Prognostic significance of PCNA grade in malignant melanoma
Prognostic significance of midwall fibrosis in dilated cardiomyopathy
Prognostic significance of Ki67 in Chinese women diagnosed with ER+/HER2− breast cancers by the 2015 St. Gallen consensus classification
Prognostic significance of low HER2 expression in gastric cancer: a retrospective, single-center analysis
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature
ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer
Targeted therapies for ER+/HER2- metastatic breast cancer
Pre-surgical cryoablation in ≤ 2 cm ER + /HER2-tumors. Prognostic factors for the presence of residual invasive carcinoma
Prognostic significance of necrosis in ampullary carcinomas
The prognostic significance of circulating tumor cell enumeration and HER2 expression by a novel automated microfluidic system in metastatic breast cancer
Pathological complete response, category change, and prognostic significance of HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of 2489 cases
Prognostic significance of PCNA grade in malignant melanoma